These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 27269057)
1. Improving the immunogenicity of a trivalent Neisseria meningitidis native outer membrane vesicle vaccine by genetic modification. Zhang L; Wen Z; Lin J; Xu H; Herbert P; Wang XM; Mehl JT; Ahl PL; Dieter L; Russell R; Kosinski MJ; Przysiecki CT Vaccine; 2016 Jul; 34(35):4250-4256. PubMed ID: 27269057 [TBL] [Abstract][Full Text] [Related]
2. A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine. Beernink PT; Vianzon V; Lewis LA; Moe GR; Granoff DM mBio; 2019 Jun; 10(3):. PubMed ID: 31213564 [TBL] [Abstract][Full Text] [Related]
3. A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccine. Pajon R; Lujan E; Granoff DM Vaccine; 2016 Jan; 34(5):643-649. PubMed ID: 26709637 [TBL] [Abstract][Full Text] [Related]
4. A Meningococcal Native Outer Membrane Vesicle Vaccine With Attenuated Endotoxin and Overexpressed Factor H Binding Protein Elicits Gonococcal Bactericidal Antibodies. Beernink PT; Ispasanie E; Lewis LA; Ram S; Moe GR; Granoff DM J Infect Dis; 2019 Mar; 219(7):1130-1137. PubMed ID: 30346576 [TBL] [Abstract][Full Text] [Related]
5. A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines. Koeberling O; Delany I; Granoff DM Clin Vaccine Immunol; 2011 May; 18(5):736-42. PubMed ID: 21367981 [TBL] [Abstract][Full Text] [Related]
6. A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice. Pajon R; Buckwalter CM; Johswich KO; Gray-Owen SD; Granoff DM Vaccine; 2015 Mar; 33(11):1317-1323. PubMed ID: 25662856 [TBL] [Abstract][Full Text] [Related]
7. Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Efron A; Brozzi A; Biolchi A; Bodini M; Giuliani M; Guidotti S; Lorenzo F; Moscoloni MA; Muzzi A; Nocita F; Pizza M; Rappuoli R; Tomei S; Vidal G; Vizzotti C; Campos J; Sorhouet Pereira C Hum Vaccin Immunother; 2024 Dec; 20(1):2378537. PubMed ID: 39037011 [TBL] [Abstract][Full Text] [Related]
8. The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein. Beernink PT; Shaughnessy J; Pajon R; Braga EM; Ram S; Granoff DM PLoS Pathog; 2012; 8(5):e1002688. PubMed ID: 22589720 [TBL] [Abstract][Full Text] [Related]
9. Binding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B Vaccine. Granoff DM; Costa I; Konar M; Giuntini S; Van Rompay KK; Beernink PT J Infect Dis; 2015 Sep; 212(5):784-92. PubMed ID: 25676468 [TBL] [Abstract][Full Text] [Related]
10. Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1. Marini A; Rossi O; Aruta MG; Micoli F; Rondini S; Guadagnuolo S; Delany I; Henderson IR; Cunningham AF; Saul A; MacLennan CA; Koeberling O PLoS One; 2017; 12(7):e0181508. PubMed ID: 28742866 [TBL] [Abstract][Full Text] [Related]
11. Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strains. Matthias KA; Reveille A; Connolly KL; Jerse AE; Gao YS; Bash MC Vaccine; 2020 Feb; 38(10):2396-2405. PubMed ID: 32037226 [TBL] [Abstract][Full Text] [Related]
12. A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on generalized modules for membrane antigens (GMMA). Koeberling O; Ispasanie E; Hauser J; Rossi O; Pluschke G; Caugant DA; Saul A; MacLennan CA Vaccine; 2014 May; 32(23):2688-95. PubMed ID: 24704334 [TBL] [Abstract][Full Text] [Related]
13. Breadth and Duration of Meningococcal Serum Bactericidal Activity in Health Care Workers and Microbiologists Immunized with the MenB-FHbp Vaccine. Lujan E; Partridge E; Giuntini S; Ram S; Granoff DM Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28566335 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the bactericidal response to an experimental Neisseria meningitidis vesicle vaccine. Moran EE; Burden R; Labrie JE; Wen Z; Wang XM; Zollinger WD; Zhang L; Pinto VB Clin Vaccine Immunol; 2012 May; 19(5):659-65. PubMed ID: 22461527 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine. Rossi R; Beernink PT; Giuntini S; Granoff DM Clin Vaccine Immunol; 2015 Dec; 22(12):1227-34. PubMed ID: 26424832 [TBL] [Abstract][Full Text] [Related]
17. Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: a phase III, randomized, multicentre, lot-to-lot consistency study. Perrett KP; McVernon J; Richmond PC; Marshall H; Nissen M; August A; Percell S; Toneatto D; Nolan T Vaccine; 2015 Sep; 33(39):5217-24. PubMed ID: 26232542 [TBL] [Abstract][Full Text] [Related]
18. Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development. Pajon R; Fergus AM; Koeberling O; Caugant DA; Granoff DM PLoS Negl Trop Dis; 2011 Sep; 5(9):e1302. PubMed ID: 21909444 [TBL] [Abstract][Full Text] [Related]
19. Meningococcal serogroup B vaccines: Estimating breadth of coverage. Donald RG; Hawkins JC; Hao L; Liberator P; Jones TR; Harris SL; Perez JL; Eiden JJ; Jansen KU; Anderson AS Hum Vaccin Immunother; 2017 Feb; 13(2):255-265. PubMed ID: 27960595 [TBL] [Abstract][Full Text] [Related]
20. Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2. Koeberling O; Giuntini S; Seubert A; Granoff DM Clin Vaccine Immunol; 2009 Feb; 16(2):156-62. PubMed ID: 19109451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]